Nivel 5 ATC
L04AC17 - Tildrakizumab
3 medicamente în această clasă
Medicamente (2)
| Nume comercial | DCI | Concentrație | Producător |
|---|---|---|---|
| ILUMETRI 100 mg | Tildrakizumabum | 100mg/ml | Sun Pharmaceutical Industries (europe) B.v. - Olanda |
| ILUMETRI 200 mg | Tildrakizumabum | 200mg/2ml | Sun Pharmaceutical Industries (europe) B.v. - Olanda |
Substanțe active în L04AC17
Clase înrudite
L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC18 Risankizumab L04AC19 Satralizumab L04AC21 (l04ac21) L04AC22 (l04ac22) L04AC24 (l04ac24)